Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
39,127,596
-
Total 13F shares
-
3,957,054
-
Share change
-
-573,691
-
Total reported value
-
$4,771,342
-
Put/Call ratio
-
47%
-
Price per share
-
$1.22
-
Number of holders
-
32
-
Value change
-
-$1,814,246
-
Number of buys
-
15
-
Number of sells
-
28
Institutional Holders of Ocean Biomedical, Inc. - Common Stock, $0.0001 par value (OCEA) as of Q2 2024
As of 30 Jun 2024,
Ocean Biomedical, Inc. - Common Stock, $0.0001 par value (OCEA) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,957,054 shares.
The largest 10 holders included
Polar Asset Management Partners Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., NORTHERN TRUST CORP, GOLDMAN SACHS GROUP INC, Verition Fund Management LLC, JANE STREET GROUP, LLC, and STATE STREET CORP.
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.